We are live on ! Find out more
GLG Partners

GLG Partners Portfolio holdings

AUM $2.14B Turnover 59.22%
1-Year Est. Return 21.14%
This Fund
S&P 500
This Quarter Est. Return
+5.42%
1 Year Est. Return
+21.14%
3 Year Est. Return
+49.84%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$2.14B
AUM Growth
+$251M
Cap. Flow
-$130M
Cap. Flow %
-6.09%
Top 10 Hldgs %
20.07%
Holding
564
New
243
Increased
78
Reduced
76
Closed
91
Avg Time Held Equity + Options
0.6 years
Top 10 Avg Time Held Equity + Options
0.2 years
Top 20 Avg Time Held Equity + Options
0.3 years
Avg Time Held Equity only
0.7 years
Top 10 Avg Time Held Equity only
0.2 years
Top 20 Avg Time Held Equity only
0.4 years

Sector Composition

Rank Sector Weight
1 Miscellaneous 27.22%
2 Consumer Discretionary 13.47%
3 Technology 9.7%
4 Financials 9.51%
5 Industrials 8.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
ETR icon
276
Entergy
ETR
$53B
$527K 0.02%
+12,948
New +$542K
2017 Q4
0 quarters
ADSK icon
277
CALL
Autodesk
ADSK
$55.6B
$524K 0.02%
+5,000
New +$583K
2017 Q4
0 quarters
LCUT icon
278
Lifetime Brands
LCUT
$180M
$521K 0.02%
31,573
– –
2017 Q2
2 quarters
CPB icon
279
Campbell's
CPB
$7.09B
$504K 0.02%
+10,471
New +$498K
2017 Q4
0 quarters
WEC icon
280
WEC Energy
WEC
$39B
$503K 0.02%
+7,574
New +$508K
2017 Q4
0 quarters
HSY icon
281
Hershey
HSY
$35.3B
$497K 0.02%
+4,378
New +$482K
2017 Q4
0 quarters
FRT icon
282
Federal Realty Investment Trust
FRT
$9.8B
$474K 0.02%
+3,568
New +$460K
2017 Q4
0 quarters
DOC icon
283
Healthpeak Properties
DOC
$13.8B
$449K 0.02%
+17,221
New +$457K
2017 Q4
0 quarters
SCG
284
DELISTED
Scana
SCG
$449K 0.02%
+11,292
New +$505K
2017 Q4
0 quarters
RL icon
285
Ralph Lauren
RL
$22.7B
$439K 0.02%
4,238
-120,964
-97% -$11.2M
2017 Q2
2 quarters
CAT icon
286
Caterpillar
CAT
$269B
$430K 0.02%
+2,730
New +$379K
2017 Q4
0 quarters
METC icon
287
Ramaco Resources Class A
METC
$418M
$430K 0.02%
64,578
-12,839
-17% -$69.1K
2017 Q1
3 quarters
MAC icon
288
Macerich
MAC
$7.12B
$429K 0.02%
+6,532
New +$400K
2017 Q4
0 quarters
PNW icon
289
Pinnacle West Capital
PNW
$12.9B
$403K 0.02%
+4,727
New +$417K
2017 Q4
0 quarters
CMS icon
290
CMS Energy
CMS
$22.3B
$392K 0.02%
+8,281
New +$401K
2017 Q4
0 quarters
TJX icon
291
TJX Companies
TJX
$146B
$392K 0.02%
+10,266
New +$372K
2017 Q4
0 quarters
MAT icon
292
Mattel
MAT
$4.3B
$389K 0.02%
+25,270
New +$400K
2017 Q4
0 quarters
HOG icon
293
Harley-Davidson
HOG
$3.28B
$379K 0.02%
7,455
-11,587
-61% -$563K
2017 Q1
3 quarters
ROST icon
294
Ross Stores
ROST
$72.4B
$362K 0.02%
+4,506
New +$315K
2017 Q4
0 quarters
VMRK icon
295
Vivmark Residential
VMRK
$50.3B
$360K 0.02%
+5,640
New +$376K
2017 Q4
0 quarters
NVDA icon
296
NVIDIA
NVDA
$3.87T
$340K 0.02%
70,240
-21,760
-24% -$108K
2017 Q1
3 quarters
CF icon
297
CALL
CF Industries
CF
$17.9B
$336K 0.02%
+7,900
New +$298K
2017 Q4
0 quarters
VZ icon
298
Verizon
VZ
$194B
$319K 0.01%
+6,023
New +$296K
2017 Q4
0 quarters
CVS icon
299
CVS Health
CVS
$116B
$315K 0.01%
+4,342
New +$316K
2017 Q4
0 quarters
OMC icon
300
Omnicom Group
OMC
$24B
$312K 0.01%
+4,288
New +$308K
2017 Q4
0 quarters

Similar funds

GLG Partners's Q4 2017 Portfolio in Review

As of Q4 2017, GLG Partners held 564 positions worth $2.14B, up 13% from $1.89B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

GLG Partners withdrew a net $130M in Q4 2017, closing 91 positions and reducing 76 holdings. Its most notable exit was Sciclone Pharmaceuticals, an estimated $29M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, down from 36% a quarter earlier, followed by Consumer Discretionary and Technology.

Against the trend, GLG Partners opened a new position in Advanced Accelerator Applications S.A. worth $49.2M.

  • GLG Partners's largest Q4 2017 buy was Advanced Accelerator Applications S.A.: 603,055 shares worth $49.2M.
  • GLG Partners added most to NXP Semiconductors in Q4 2017, an estimated $35M increase.
  • GLG Partners's biggest Q4 2017 reduction was Criteo, cutting an estimated $22.5M.
  • GLG Partners fully exited Sciclone Pharmaceuticals in Q4 2017, selling an estimated $29M.
  • GLG Partners's ten largest holdings make up 20% of its $2.14B portfolio in Q4 2017.
  • GLG Partners opened 243 new positions and closed 91 in Q4 2017.
  • GLG Partners's portfolio value rose 13% quarter-over-quarter to $2.14B.

Based on GLG Partners's 13F filing for Q4 2017, filed 14 Feb 2018.